Spironolactone Tablet
Product Images NDC 0615-8451

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 0615-8451). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Str1 (Spironolactone Tabs 8451 8452 1)

Chemical structure diagram of spironolactone, depicting its steroidal core with attached functional groups including lactone and thioacetate moieties.*

FDA Label Image

Fig1 (Spironolactone Tabs 8451 8452 2)

A Kaplan-Meier survival curve chart comparing the probability of an outcome over time in months for two groups: one treated with spironolactone and the other with placebo. The chart shows higher survival probability for spironolactone, with statistical significance indicated by a log-rank p-value less than 0.001.*

FDA Label Image

Fig2 (Spironolactone Tabs 8451 8452 3)

A forest plot showing hazard ratios (HR) and 95% confidence intervals (CI) across various subgroups for spironolactone compared to placebo. The subgroups include age ranges, sex, race, LVEF percentages, heart failure type, NYHA class, diabetes status, serum creatinine levels, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The plot visually compares the effectiveness of spironolactone relative to placebo in these categories.*

FDA Label Image

Prinicpal Display Panel (Spironolactone Tabs 8451 8452 4)

This package label is for Spironolactone Tablets USP 50 mg, an oral tablet manufactured by Aurobindo and packaged by Vanguard Labs in Glasgow, KY. The label includes barcodes, lot number 8452, and space for expiration date and quantity of 30 tablets. The label also features dispensing instructions and is marked for institutional use only.*

FDA Label Image

Principal Display Panel (25 mg)

This is a packaging label for Spironolactone Tablets USP 25 mg, oral dosage form. The label includes manufacturer details, listing Aurobindo as the manufacturer and packaging by Vanguard Labs, Glasgow, KY. It features multiple barcodes, lot number placeholders (LOT 8451), and expiration date (EXP) fields. The label advises storage between 20-25°C (68°-77°F) and instructs dispensing in a tight, light-resistant container, noting institutional use only.*

FDA Label Image

Principal Display Panel (25 mg)

Spironolactone Tablets USP 25 mg oral tablets label by NCS HealthCare of KY, LLC dba Vangard Labs. The image shows multiple smaller labels for Spironolactone USP 25 mg with lot and expiration placeholders and barcodes. Includes a primary label with storage instructions (20°-25°C), quantity 30, Rx only, and manufacturing information by Aurobindo with repackaging by Vangard Labs in Glasgow, KY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.